See News Archive Button
Or filter your current search. Health Affairs Project Hope [01 Jan , 27 1: Abstract South Korea's National Health Insurance recently announced a reform in pharmaceutical reimbursement, with the purpose of increasing rational resource use in drug spending. The new policy aims to take the cost-effectiveness and budget impact of newly introduced drugs into account in payment decisions.
If the policy is implemented, South Korea will be the first Asian country to officially adopt economic evaluation as a tool for resource allocation in health care. This paper looks at the background, objectives, expected outcomes, potential issues, and resulting trade conflict regarding use of economic data in drug reimbursement decisions in South Korea.http://cszplayers.com/221.php
CDE – Center for Drug Evaluation
The reports for application of new drug reimbusement listing were for BNHI internal use only. There is no regular publication plan for public communication so far.
On the other hand, most of the research projects are budget impact analysis for a group of treatment requested by DBC. We will look for the opportunity to release research findings and reports through media, website, symposium and peer-reviewed literature as appropriate.
- 2006 Economic Issues - Overheating, or is The Party Ending - Articles and Essays - Volume VIII (Lance Winslow Economic Series Book 8).
- Evaluating Pharmaceuticals for Health Policy and Reimbursement.
- Site not found · GitHub Pages;
- Золотарь (Russian Edition).
The first research project report would be expected in November this year. Website homepage of HTA division will be established in May Our keen understanding of the often conflicting objectives and motivations of healthcare system stakeholders allows us to create actionable reimbursement strategies that support the range of reimbursement activity — from planning through implementation and ongoing support.
- Reimbursement & Market Access.
- The Love Den Diaries Special Edition Bundle Pack - Unlock The Secrets?
- Death of an Old Master (Lord Francis Powerscourt Series Book 3).
- Manual to Life!
Our research panel contacts provide insights to help assess and drive positive coverage and decision making and include private managed care organizations MCOs , preferred provider organizations PPOs and indemnity insurers, pharmacy benefit management organizations PBMs , technology assessment firms, and Medicare and Medicaid as well as hospital and provider organizations, physicians, KOLs, and patients. Objective An international pharmaceutical company needed an initial reimbursement assessment of both the inpatient and outpatient environments for their target product.
CDE – Center for Drug Evaluation | INAHTA
Boston Healthcare was engaged to provide the full range of reimbursement services necessary to support product launch. Outcome Boston Healthcare detailed the critical path and timeline for the relevant coding process through our stakeholder relationships and enlisting coding advocates in anticipation of submitting a novel code.
Boston Healthcare developed the key criteria for interviewing and evaluating hotline vendors by conducting a reimbursement hotline needs analysis for the target product and two additional products. Boston Healthcare was able to execute the tactical elements of the reimbursement strategic plan and develop the subsequent U. Objective A diagnostics company was preparing to launch a new in vitro diagnostic test. Realizing that gaining reimbursement would be critical, particularly with Medicare, the manufacturer engaged Boston Healthcare to assess the situation and develop a strategy for coding and coverage.